Research ArticleSpecial Section on Emerging Novel Enzyme Pathways in Drug Metabolism
Discovery of a Novel Microsomal Epoxide Hydrolase–Catalyzed Hydration of a Spiro Oxetane
Xue-Qing Li, Martin A. Hayes, Gunnar Grönberg, Kristina Berggren, Neal Castagnoli Jr. and Lars Weidolf
Drug Metabolism and Disposition August 2016, 44 (8) 1341-1348; DOI: https://doi.org/10.1124/dmd.116.071142
Xue-Qing Li
Cardiovascular and Metabolic Diseases(X.-Q.L., M.A.H., L.W.) and Respiratory, Inflammation, and Autoimmune Disease (G.G., K.B.), Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden; and Department of Chemistry, Virginia Tech, Blacksburg, Virginia (N.C.)
Martin A. Hayes
Cardiovascular and Metabolic Diseases(X.-Q.L., M.A.H., L.W.) and Respiratory, Inflammation, and Autoimmune Disease (G.G., K.B.), Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden; and Department of Chemistry, Virginia Tech, Blacksburg, Virginia (N.C.)
Gunnar Grönberg
Cardiovascular and Metabolic Diseases(X.-Q.L., M.A.H., L.W.) and Respiratory, Inflammation, and Autoimmune Disease (G.G., K.B.), Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden; and Department of Chemistry, Virginia Tech, Blacksburg, Virginia (N.C.)
Kristina Berggren
Cardiovascular and Metabolic Diseases(X.-Q.L., M.A.H., L.W.) and Respiratory, Inflammation, and Autoimmune Disease (G.G., K.B.), Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden; and Department of Chemistry, Virginia Tech, Blacksburg, Virginia (N.C.)
Neal Castagnoli Jr.
Cardiovascular and Metabolic Diseases(X.-Q.L., M.A.H., L.W.) and Respiratory, Inflammation, and Autoimmune Disease (G.G., K.B.), Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden; and Department of Chemistry, Virginia Tech, Blacksburg, Virginia (N.C.)
Lars Weidolf
Cardiovascular and Metabolic Diseases(X.-Q.L., M.A.H., L.W.) and Respiratory, Inflammation, and Autoimmune Disease (G.G., K.B.), Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden; and Department of Chemistry, Virginia Tech, Blacksburg, Virginia (N.C.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleSpecial Section on Emerging Novel Enzyme Pathways in Drug Metabolism
Microsomal Epoxide Hydrolase–Catalyzed Hydration of an Oxetane
Xue-Qing Li, Martin A. Hayes, Gunnar Grönberg, Kristina Berggren, Neal Castagnoli and Lars Weidolf
Drug Metabolism and Disposition August 1, 2016, 44 (8) 1341-1348; DOI: https://doi.org/10.1124/dmd.116.071142
Research ArticleSpecial Section on Emerging Novel Enzyme Pathways in Drug Metabolism
Microsomal Epoxide Hydrolase–Catalyzed Hydration of an Oxetane
Xue-Qing Li, Martin A. Hayes, Gunnar Grönberg, Kristina Berggren, Neal Castagnoli and Lars Weidolf
Drug Metabolism and Disposition August 1, 2016, 44 (8) 1341-1348; DOI: https://doi.org/10.1124/dmd.116.071142